News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Researchers Give Link Technologies Ltd Resounding Endorsement



3/12/2012 11:09:46 AM

BELLSHILL, SCOTLAND, 12 March 2012: Link Technologies Ltd, an ISO 9001:2008 certified specialist oligonucleotide reagent manufacturer, has announced the results of its latest customer survey. Responses from the hundreds of customers polled, all of which are users of custom oligonucleotide synthesis reagents and precursors, unanimously cited the quality of the Link’s products as a primary reason to buy from the company. In addition, most current customers believed that the level of customer service offered by Link was exceptional, giving it an average of 9.3 out of 10. They also indicated that they would enthusiastically recommend Link to a colleague.

Dr Catherine McKeen, Technical Manager at Link Technologies, commented: “The specialist reagents and precursors we provide allow researchers to work at the cutting edge of oligonucleotide applications in life science and drug discovery. As experts in the field, we understand that quality is paramount, a view that is shared by our customers. We also believe in offering the best possible service and rapid delivery times, allowing our customers to work quickly and confidently, safe in the knowledge that they are working with the highest quality building blocks and reagents.”

For more information please visit the Link Technologies website at www.linktech.co.uk or follow us on Twitter: @linktechdna.

About Link Technologies Ltd

Link Technologies Ltd is a leading kilo-scale supplier of speciality reagents for oligonucleotide synthesis and modification, all to the ISO 9001:2008 quality certification. The company’s main markets are university and commercial research departments, plus, increasingly, larger Contract Manufacturing Organisations (CMOs) in the biotech sector.

Link has also forged successful links to academia working closely with many UK universities. In tandem with internal research and development, the Company has an excellent record in bringing in-licence products to market with various worldwide commercial partners.

For further information see: www.linktech.co.uk


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES